Friday, July 19, 2024
spot_img
HomeBusinessNamita Thapar may gain ₹127 crore in Emcure Pharma IPO

Namita Thapar may gain ₹127 crore in Emcure Pharma IPO

Namita Thapar may gain ₹127 crore in Emcure Pharma IPO


Namita Thapar will gain around 127 crore through the IPO of Emcure Pharmaceuticals which will kick off this week. Namita Thapar acquired shares in Emcure at a weighted average price of 3.44 apiece. Through the IPO, she will offload a partial stake of about 12.68 lakh shares under the offer for sale (OFS) component. At the upper price band of 1,008, the stake sale will fetch around 127 crore for Namita Thapar who holds around 63 lakh shares or 3.5% in the company.

Namita Thapar is one of the sharks on Shark Tank India.

Emcure Pharmaceuticals IPO comprises fresh issue of equity shares worth 800 crore and an OFS of 1.14 crore equity shares by promoters and existing shareholders. The company said that net proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.

The Pune based company is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products.

In FY24, the company’s revenue from operations grew 11% year-on-year (YoY) to 6,658 crore from 5,985 crore in the previous financial year. Book-running lead managers to the issue Kotak Mahindra Capital Company, Jefferies India, Axis Capital and JPMorgan India.



Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments